{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:45:42Z","timestamp":1791315942362,"version":"4.3.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09543-9","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T17:54:25Z","timestamp":1768499665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic and metabolic rewiring in metastatic pheochromocytomas and paragangliomas driven by SDHB mutations"],"prefix":"10.1038","volume":"9","author":[{"given":"Tamara","family":"Cubiella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Alba-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-9408","authenticated-orcid":false,"given":"Jaime","family":"San-Juan-Guardado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Suarez-Priede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"G\u00f3mez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6891-0671","authenticated-orcid":false,"given":"Maria","family":"Tous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Villabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Del Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Forga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-257X","authenticated-orcid":false,"given":"Nuria","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-2603","authenticated-orcid":false,"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1112-1583","authenticated-orcid":false,"given":"Mar\u00eda-Dolores","family":"Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"9543_CR1","doi-asserted-by":"crossref","first-page":"112344","DOI":"10.1016\/j.mce.2024.112344","volume":"592","author":"J Varghese","year":"2024","unstructured":"Varghese, J., Skefos, C. M. & Jimenez, C. Metastatic pheochromocytoma and paraganglioma: integrating tumor biology in clinical practice. Mol. Cell Endocrinol. 592, 112344 (2024).","journal-title":"Mol. Cell Endocrinol."},{"key":"9543_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti, D. et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49\u201354 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"9543_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","volume":"11","author":"J-P Bayley","year":"2010","unstructured":"Bayley, J.-P. et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 11, 366\u2013372 (2010).","journal-title":"Lancet Oncol."},{"key":"9543_CR4","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011\u20133020 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"9543_CR5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848\u2013851 (2000).","journal-title":"Science"},{"key":"9543_CR6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouz\u00e9","year":"2013","unstructured":"Letouz\u00e9, E. et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23, 739\u2013752 (2013).","journal-title":"Cancer Cell"},{"key":"9543_CR7","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1078-0432.CCR-07-1867","volume":"14","author":"J Geli","year":"2008","unstructured":"Geli, J. et al. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior. Clin. Cancer Res. 14, 2551\u20132559 (2008).","journal-title":"Clin. Cancer Res."},{"key":"9543_CR8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard, P. J. et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231\u20132239 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"9543_CR9","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","volume":"91","author":"PJ Pollard","year":"2006","unstructured":"Pollard, P. J. et al. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J. Clin. Endocrinol. Metab. 91, 4593\u20134598 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9543_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77\u201385 (2005).","journal-title":"Cancer Cell"},{"key":"9543_CR11","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-8-89","volume":"8","author":"AM Cervera","year":"2009","unstructured":"Cervera, A. M., Bayley, J.-P., Devilee, P. & McCreath, K. J. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol. Cancer 8, 89 (2009).","journal-title":"Mol. Cancer"},{"key":"9543_CR12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M. et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326\u20131338 (2012).","journal-title":"Genes Dev."},{"key":"9543_CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","volume":"3","author":"JK Killian","year":"2013","unstructured":"Killian, J. K. et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 3, 648\u2013657 (2013).","journal-title":"Cancer Discov."},{"key":"9543_CR14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1677\/ERC-09-0316","volume":"17","author":"A Blank","year":"2010","unstructured":"Blank, A. et al. SDHB loss predicts malignancy in pheochromocytomas\/sympathethic paragangliomas, but not through hypoxia signalling. Endocr. Relat. cancer 17, 919\u2013928 (2010).","journal-title":"Endocr. Relat. cancer"},{"key":"9543_CR15","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","volume":"30","author":"A Morin","year":"2020","unstructured":"Morin, A. et al. TET-mediated hypermethylation primes SDH-deficient cells for HIF2\u03b1-driven mesenchymal transition. Cell Rep. 30, 4551\u20134566.e7 (2020).","journal-title":"Cell Rep."},{"key":"9543_CR16","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","volume":"21","author":"AA de Cubas","year":"2015","unstructured":"de Cubas, A. A. et al. DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers. Clin. Cancer Res 21, 3020\u20133030 (2015).","journal-title":"Clin. Cancer Res"},{"key":"9543_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","volume":"20","author":"D Ta\u00efeb","year":"2024","unstructured":"Ta\u00efeb, D. et al. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement. Nat. Rev. Endocrinol. 20, 168\u2013184 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"9543_CR18","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2589-7500(23)00094-8","volume":"5","author":"C Pamporaki","year":"2023","unstructured":"Pamporaki, C. et al. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort. Lancet Digit. Health 5, e551\u2013e559 (2023).","journal-title":"Lancet Digit. Health"},{"key":"9543_CR19","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-023-01598-3","volume":"15","author":"P Chatzikyriakou","year":"2023","unstructured":"Chatzikyriakou, P. et al. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide. Clin. Epigenetics 15, 196 (2023).","journal-title":"Clin. Epigenetics"},{"key":"9543_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181\u2013193 (2017).","journal-title":"Cancer Cell"},{"key":"9543_CR21","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1210\/jc.2018-01471","volume":"104","author":"C Bernardo-Casti\u00f1eira","year":"2019","unstructured":"Bernardo-Casti\u00f1eira, C. et al. Epigenetic deregulation of protocadherin PCDHGC3 in pheochromocytomas\/paragangliomas associated with SDHB mutations. J. Clin. Endocrinol. Metab. 104, 5673\u20135692 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9543_CR22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10555-023-10120-3","volume":"42","author":"M Janin","year":"2023","unstructured":"Janin, M., Davalos, V. & Esteller, M. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. Cancer Metastasis Rev. 42, 1071\u20131112 (2023).","journal-title":"Cancer Metastasis Rev."},{"key":"9543_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald, O. G. et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat. Genet. 49, 367\u2013376 (2017).","journal-title":"Nat. Genet."},{"key":"9543_CR24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/2159-8290.CD-24-0943","volume":"15","author":"C Arenillas","year":"2025","unstructured":"Arenillas, C. et al. Convergent genetic adaptation in human tumors developed under systemic hypoxia and in populations living at high altitudes. Cancer Discov. 15, 1037\u20131062 (2025).","journal-title":"Cancer Discov."},{"key":"9543_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41568-024-00789-1","volume":"25","author":"D Senft","year":"2025","unstructured":"Senft, D. Fructose takes a detour to feed cancer. Nat. Rev. Cancer 25, 77 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"9543_CR26","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.currproblcancer.2024.101116","volume":"51","author":"V Sukrithan","year":"2024","unstructured":"Sukrithan, V., Perez, K., Pandit-Taskar, N. & Jimenez, C. Management of metastatic pheochromocytomas and paragangliomas: when and what. Curr. Probl. Cancer 51, 101116 (2024).","journal-title":"Curr. Probl. Cancer"},{"key":"9543_CR27","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.3390\/cancers14122986","volume":"14","author":"L Celada","year":"2022","unstructured":"Celada, L. et al. Differential HIF2\u03b1 protein expression in human carotid body and adrenal medulla under physiologic and tumorigenic conditions. Cancers (Basel) 14, 2986 (2022).","journal-title":"Cancers (Basel)"},{"key":"9543_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","volume":"43","author":"S N\u00f6lting","year":"2022","unstructured":"N\u00f6lting, S. et al. Personalized management of pheochromocytoma and paraganglioma. Endocr. Rev. 43, 199\u2013239 (2022).","journal-title":"Endocr. Rev."},{"key":"9543_CR29","doi-asserted-by":"crossref","first-page":"R237","DOI":"10.1152\/ajpregu.00093.2014","volume":"307","author":"Y Shao","year":"2014","unstructured":"Shao, Y., Wellman, T. L., Lounsbury, K. M. & Zhao, F.-Q. Differential regulation of GLUT1 and GLUT8 expression by hypoxia in mammary epithelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R237\u2013R247 (2014).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"9543_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03985","volume":"6","author":"T Kido","year":"2020","unstructured":"Kido, T. et al. Glucose transporter 1 is important for the glycolytic metabolism of human endometrial stromal cells in hypoxic environment. Heliyon 6, e03985 (2020).","journal-title":"Heliyon"},{"key":"9543_CR31","doi-asserted-by":"crossref","first-page":"102137","DOI":"10.1016\/j.gde.2023.102137","volume":"84","author":"H Bharti","year":"2024","unstructured":"Bharti, H., Han, S., Chang, H.-W. & Reinberg, D. Polycomb repressive complex 2 accessory factors: rheostats for cell fate decision? Curr. Opin. Genet. Dev. 84, 102137 (2024).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"9543_CR32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2741\/4760","volume":"24","author":"A Batool","year":"2019","unstructured":"Batool, A., Jin, C. & Liu, Y.-X. Role of EZH2 in cell lineage determination and relative signaling pathways. Front. Biosci. (Landmark Ed.) 24, 947\u2013960 (2019).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"9543_CR33","doi-asserted-by":"crossref","first-page":"100180","DOI":"10.1016\/j.cellin.2024.100180","volume":"3","author":"L Jiang","year":"2024","unstructured":"Jiang, L., Huang, L. & Jiang, W. H3K27me3-mediated epigenetic regulation in pluripotency maintenance and lineage differentiation. Cell Insight 3, 100180 (2024).","journal-title":"Cell Insight"},{"key":"9543_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/epigenomes6030023","volume":"6","author":"CH Loh","year":"2022","unstructured":"Loh, C. H. & Veenstra, G. J. C. The role of polycomb proteins in cell lineage commitment and embryonic development. Epigenomes 6, 23 (2022).","journal-title":"Epigenomes"},{"key":"9543_CR35","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/genes12101485","volume":"12","author":"P Flora","year":"2021","unstructured":"Flora, P., Dalal, G., Cohen, I. & Ezhkova, E. Polycomb repressive complex(es) and their role in adult stem cells. Genes (Basel) 12, 1485 (2021).","journal-title":"Genes (Basel)"},{"key":"9543_CR36","volume":"77","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor. EBioMedicine 77, 103872 (2022).","journal-title":"EBioMedicine"},{"key":"9543_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07607-y","volume":"16","author":"MC Nocito","year":"2025","unstructured":"Nocito, M. C. et al. A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis. Cell Death Dis. 16, 291 (2025).","journal-title":"Cell Death Dis."},{"key":"9543_CR38","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101931","volume":"38","author":"M Monteagudo","year":"2024","unstructured":"Monteagudo, M. et al. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma. Best. Pract. Res. Clin. Endocrinol. Metab. 38, 101931 (2024).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"9543_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s10020-024-00879-8","volume":"30","author":"N Hadzi-Petrushev","year":"2024","unstructured":"Hadzi-Petrushev, N. et al. GLUT5-overexpression-related tumorigenic implications. Mol. Med. 30, 114 (2024).","journal-title":"Mol. Med."},{"key":"9543_CR40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41420-018-0038-5","volume":"4","author":"Y Weng","year":"2018","unstructured":"Weng, Y. et al. SLC2A5 promotes lung adenocarcinoma cell growth and metastasis by enhancing fructose utilization. Cell Death Discov. 4, 38 (2018).","journal-title":"Cell Death Discov."},{"key":"9543_CR41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbrc.2018.04.103","volume":"500","author":"C Su","year":"2018","unstructured":"Su, C., Li, H. & Gao, W. GLUT5 increases fructose utilization and promotes tumor progression in glioma. Biochem. Biophys. Res. Commun. 500, 462\u2013469 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9543_CR42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15580","volume":"183","author":"P Zhao","year":"2018","unstructured":"Zhao, P. et al. SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia. Br. J. Haematol. 183, 242\u2013250 (2018).","journal-title":"Br. J. Haematol."},{"key":"9543_CR43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-021-00246-9","volume":"9","author":"RJ Liang","year":"2021","unstructured":"Liang, R. J. et al. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metab. 9, 12 (2021).","journal-title":"Cancer Metab."},{"key":"9543_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215617","volume":"534","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer. Cancer Lett. 534, 215617 (2022).","journal-title":"Cancer Lett."},{"key":"9543_CR45","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s12094-022-03015-2","volume":"25","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis\/AKT pathway. Clin. Transl. Oncol. 25, 1080\u20131090 (2023).","journal-title":"Clin. Transl. Oncol."},{"key":"9543_CR46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.devcel.2024.04.023","volume":"59","author":"P-C Yu","year":"2024","unstructured":"Yu, P.-C. et al. SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis. Dev. Cell 59, 1954\u20131971.e7 (2024).","journal-title":"Dev. Cell"},{"key":"9543_CR47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.brainres.2016.12.022","volume":"1657","author":"SA Oppelt","year":"2017","unstructured":"Oppelt, S. A., Zhang, W. & Tolan, D. R. Specific regions of the brain are capable of fructose metabolism. Brain Res. 1657, 312\u2013322 (2017).","journal-title":"Brain Res."},{"key":"9543_CR48","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan, H. et al. Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metab. 36, 2449\u20132467.e6 (2024).","journal-title":"Cell Metab."},{"key":"9543_CR49","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"9543_CR50","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gkt090","volume":"41","author":"TJ Triche","year":"2013","unstructured":"Triche, T. J., Weisenberger, D. J., Van Den Berg, D., Laird, P. W. & Siegmund, K. D. Low-level processing of illumina infinium DNA methylation BeadArrays. Nucleic Acids Res. 41, e90 (2013).","journal-title":"Nucleic Acids Res."},{"key":"9543_CR51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189\u2013196 (2013).","journal-title":"Bioinformatics"},{"key":"9543_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).","journal-title":"Genome Biol."},{"key":"9543_CR53","volume":"11","author":"P Du","year":"2010","unstructured":"Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinforma. 11, 587 (2010).","journal-title":"BMC Bioinforma."},{"key":"9543_CR54","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"9543_CR55","doi-asserted-by":"crossref","first-page":"Article39","DOI":"10.2202\/1544-6115.1585","volume":"9","author":"B Phipson","year":"2010","unstructured":"Phipson, B. & Smyth, G. K. Permutation P-values should never be zero: calculating exact P-values when permutations are randomly drawn. Stat. Appl. Genet. Mol. Biol. 9, Article39 (2010).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"9543_CR56","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1093\/bioinformatics\/bts545","volume":"28","author":"BS Pedersen","year":"2012","unstructured":"Pedersen, B. S., Schwartz, D. A., Yang, I. V. & Kechris, K. J. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics 28, 2986\u20132988 (2012).","journal-title":"Bioinformatics"},{"key":"9543_CR57","volume":"44","author":"Z Xu","year":"2016","unstructured":"Xu, Z., Niu, L., Li, L. & Taylor, J. A. ENmix: a novel background correction method for Illumina HumanMethylation450 BeadChip. Nucleic Acids Res. 44, e20 (2016).","journal-title":"Nucleic Acids Res."},{"key":"9543_CR58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Maksimovic, J. & Oshlack, A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics 32, 286\u2013288 (2016).","journal-title":"Bioinformatics"},{"key":"9543_CR59","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09543-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:20:39Z","timestamp":1771345239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09543-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9543"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09543-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}